Skip to main content
Premium Trial:

Request an Annual Quote

UK's Institute of Cancer Research Taps Dotmatics' Software for Drug Discovery Work

Premium

Dotmatics said this week that the Institute of Cancer Research, London, has licensed Vortex, its data visualization and analysis tool, for use in cancer drug research and development efforts.

Julian Blagg, who heads ICR’s chemistry department and is the deputy director of its cancer therapeutics division, said that the institute selected Vortex, after internal testing, because of its "flexibility, ease of use and swift integration with our existing chemoinformatics data storage platform.”

The financial details of the licensing agreement were not disclosed.

Another oncology-focused client of Dotmatics is Cancer Therapeutics CRC, a small-molecule drug discovery company based in Bundoora, Australia.

The company uses Dotmatics’ platform to query and analyze data from cancer pathways associated with the tumor microenvironment or growth in breast, prostate, melanoma, lung, and brain cancers (BI 6/8/2012).

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.